Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enzira 2010/2011 influenza vaccine immunogenicity and safety study in adults and older adults
2010-019532-12Phase 4Completed
- Sponsor
- CSL Limited
- Start
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of omeprazole in influenza (2 arms), sponsored by CSL Limited. Primary endpoints: Immunogenicity according to CPMP criteria in the adult cohort, Immunogenicity according to CPMP criteria in the older adult cohort and 2 more. Started Mar 2010; status: completed.
02
Drugs
omeprazole
03
Conditions
influenza
Beyond the preview
Go deeper on 2010-019532-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019532-12.